$2.90
-0.08[-2.68%]
At close: Apr 23
$2.90
0[0.00%]
PreMarket: 7:21PM EDT
Organogenesis Hldgs
(NASDAQ:ORGO)Organogenesis Hldgs Stock (NASDAQ:ORGO), Analyst Ratings, Price Targets, Predictions
Organogenesis Holdings Inc has a consensus price target of $14.25, established from looking at the 12 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, Cantor Fitzgerald, and BTIG on March 1, 2024, February 7, 2024, and December 27, 2023. With an average price target of $5.33 between Cantor Fitzgerald, Cantor Fitzgerald, and BTIG, there's an implied 83.91% upside for Organogenesis Holdings Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
BTIG
Morgan Stanley
SVB Leerink
Credit Suisse
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Organogenesis Hldgs
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/01/2024 | ORGO | Buy Now | Organogenesis Hldgs | $2.90 | 72.41% | Cantor Fitzgerald | Ross Osborn | → $5 | Reiterates | Overweight → Overweight | Get Alert |
| 02/07/2024 | ORGO | Buy Now | Organogenesis Hldgs | $2.90 | 72.41% | Cantor Fitzgerald | Ross Osborn | → $5 | Initiates | → Overweight | Get Alert |
| 12/27/2023 | ORGO | Buy Now | Organogenesis Hldgs | $2.90 | 106.9% | BTIG | Ryan Zimmerman | $4 → $6 | Maintains | Buy | Get Alert |
| 11/14/2023 | ORGO | Buy Now | Organogenesis Hldgs | $2.90 | 20.69% | Morgan Stanley | Drew Ranieri | $3 → $3.5 | Maintains | Equal-Weight | Get Alert |
| 08/11/2023 | ORGO | Buy Now | Organogenesis Hldgs | $2.90 | 3.45% | Morgan Stanley | Drew Ranieri | $5 → $3 | Maintains | Equal-Weight | Get Alert |
| 08/10/2023 | ORGO | Buy Now | Organogenesis Hldgs | $2.90 | 37.93% | BTIG | Ryan Zimmerman | $10 → $4 | Maintains | Buy | Get Alert |
| 06/15/2023 | ORGO | Buy Now | Organogenesis Hldgs | $2.90 | 72.41% | Morgan Stanley | Drew Ranieri | → $5 | Initiates | → Equal-Weight | Get Alert |
| 05/24/2023 | ORGO | Buy Now | Organogenesis Hldgs | $2.90 | 244.83% | BTIG | Ryan Zimmerman | → $10 | Upgrade | Neutral → Buy | Get Alert |
| 11/10/2022 | ORGO | Buy Now | Organogenesis Hldgs | $2.90 | — | BTIG | Ryan Zimmerman | — | Downgrade | Buy → Neutral | Get Alert |
| 11/10/2021 | ORGO | Buy Now | Organogenesis Holdings | $2.90 | 589.66% | SVB Leerink | Danielle Antalffy | — | Maintains | Outperform | Get Alert |
| 08/10/2021 | ORGO | Buy Now | Organogenesis Holdings | $2.90 | 762.07% | Credit Suisse | Matt Miksic | — | Maintains | Outperform | Get Alert |
| 05/11/2021 | ORGO | Buy Now | Organogenesis Holdings | $2.90 | 796.55% | SVB Leerink | Richard Newitter | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Organogenesis Hldgs (ORGO)?
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Cantor Fitzgerald on March 1, 2024. The analyst firm set a price target for $5.00 expecting ORGO to rise to within 12 months (a possible 72.41% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Organogenesis Hldgs (ORGO)?
The latest analyst rating for Organogenesis Hldgs (NASDAQ: ORGO) was provided by Cantor Fitzgerald, and Organogenesis Hldgs reiterated their overweight rating.
When was the last upgrade for Organogenesis Hldgs (ORGO)?
The last upgrade for Organogenesis Holdings Inc happened on May 24, 2023 when BTIG raised their price target to $10. BTIG previously had a neutral for Organogenesis Holdings Inc.
When was the last downgrade for Organogenesis Hldgs (ORGO)?
The last downgrade for Organogenesis Holdings Inc happened on November 10, 2022 when BTIG changed their price target from N/A to N/A for Organogenesis Holdings Inc.
When is the next analyst rating going to be posted or updated for Organogenesis Hldgs (ORGO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Organogenesis Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Organogenesis Hldgs was filed on March 1, 2024 so you should expect the next rating to be made available sometime around March 1, 2025.
Is the Analyst Rating Organogenesis Hldgs (ORGO) correct?
While ratings are subjective and will change, the latest Organogenesis Hldgs (ORGO) rating was a reiterated with a price target of $0.00 to $5.00. The current price Organogenesis Hldgs (ORGO) is trading at is $2.90, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.